| Financial Year |
March 31 2023 |
| Monetary Funds |
2,912,834.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,699,314.92 |
| Accounts Receivable |
81,358,162.15 |
| Advances to Suppliers |
17,959,094.85 |
| Other Receivables |
13,886,536.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
168,864,215.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,836,643.15 |
| Total Current Assets |
293,516,802.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
216,063,192.65 |
| Under-construction Projects |
3,222,595.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,125,208.39 |
| R&D expenses |
-- |
| Goodwill |
12,413,843.37 |
| Long-Term Deferred and Prepaid Expenses |
2,098,190.08 |
| Deferred Income Tax Assets |
25,369,720.95 |
| Other Non-Current Assets |
2,091,861.71 |
| Sub-Total of Non-Current Assets |
312,530,362.84 |
| Total Assets |
606,047,165.22 |
| Short-Term Loans |
180,920,916.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,067,662.44 |
| Accounts Payable |
45,261,925.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,717,425.58 |
| Taxes Payable |
1,498,182.08 |
| Interest Payable |
1,632,099.99 |
| Dividend Payable |
-- |
| Other payables |
105,614,768.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
35,128,530.68 |
| Other Current Liabilities |
586,681.61 |
| Sub-Total of Current Liabilities |
382,836,634.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,284,336.44 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,447,023.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,079,360.24 |
| Total Liabilities |
417,915,995.03 |
| Paid-In Capital(Or Share Stock) |
124,168,800.00 |
| Capital Surplus |
-- |
| Surplus Reserve |
22,766,712.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-214,573,486.83 |
| Minority Stockholder's Interest |
18,019,664.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
170,111,505.28 |
| Owner's Equity（Stockholder's Equity） |
188,131,170.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
606,047,165.22 |
